Your browser is no longer supported. Please, upgrade your browser.
JNJ Johnson & Johnson daily Stock Chart
JNJ [NYSE]
Johnson & Johnson
IndexDJIA S&P500 P/E25.73 EPS (ttm)5.25 Insider Own0.07% Shs Outstand2.64B Perf Week1.46%
Market Cap355.59B Forward P/E14.90 EPS next Y9.05 Insider Trans0.17% Shs Float2.63B Perf Month-0.90%
Income14.15B PEG4.32 EPS next Q1.87 Inst Own70.50% Short Float0.64% Perf Quarter2.03%
Sales81.71B P/S4.35 EPS this Y7.60% Inst Trans0.53% Short Ratio2.23 Perf Half Y-2.51%
Book/sh22.09 P/B6.11 EPS next Y4.38% ROA9.20% Target Price150.24 Perf Year-6.45%
Cash/sh6.81 P/C19.82 EPS next 5Y5.96% ROE23.80% 52W Range121.00 - 148.99 Perf YTD4.56%
Dividend3.80 P/FCF36.00 EPS past 5Y3.10% ROI17.00% 52W High-9.43% Beta0.70
Dividend %2.82% Quick Ratio1.00 Sales past 5Y2.70% Gross Margin66.60% 52W Low11.52% ATR2.30
Employees135100 Current Ratio1.30 Sales Q/Q1.90% Oper. Margin19.90% RSI (14)61.55 Volatility1.29% 1.67%
OptionableYes Debt/Eq0.49 EPS Q/Q-54.50% Profit Margin17.30% Rel Volume1.14 Prev Close130.96
ShortableYes LT Debt/Eq0.46 EarningsOct 15 BMO Payout69.50% Avg Volume7.61M Price134.94
Recom2.10 SMA203.54% SMA503.28% SMA2000.19% Volume8,640,304 Change3.04%
Oct-16-19Upgrade Atlantic Equities Underweight → Neutral
Oct-11-19Upgrade Bernstein Mkt Perform → Outperform $155
Jul-12-19Resumed Credit Suisse Outperform $156
May-28-19Initiated Goldman Buy
Jan-23-19Reiterated Barclays Equal Weight $137 → $135
Jul-12-18Upgrade Goldman Sell → Neutral
Jun-27-18Initiated Bernstein Mkt Perform $129
Apr-23-18Reiterated Citigroup Neutral $146 → $134
Apr-18-18Reiterated Stifel Hold $145 → $135
Jan-24-18Reiterated Stifel Hold $142 → $145
Jan-12-18Reiterated Wells Fargo Outperform $155 → $160
Jan-02-18Downgrade JP Morgan Overweight → Neutral
Oct-18-17Reiterated Stifel Hold $140 → $142
Oct-18-17Reiterated RBC Capital Mkts Outperform $144 → $147
Oct-18-17Reiterated Leerink Partners Outperform $150 → $165
Oct-16-17Reiterated Jefferies Buy $157 → $160
Oct-11-17Upgrade Jefferies Hold → Buy
Oct-09-17Upgrade Wells Fargo Market Perform → Outperform
Sep-25-17Initiated Citigroup Neutral $140
Sep-20-17Downgrade Goldman Neutral → Sell $125 → $130
Nov-17-19 07:07AM  Hedge Funds Open Kimono: 5 Best Healthcare Stocks To Buy Insider Monkey
Nov-15-19 05:47PM  US Indexes Close Higher Friday and for the Week GuruFocus.com
03:24PM  UPDATE 2-Oklahoma judge reduces Johnson & Johnson opioid payout to $465 million Reuters
03:13PM  Oklahoma judge reduces Johnson & Johnson payout in opioid case to $465 million Reuters
03:13PM  Oklahoma judge reduces Johnson & Johnson opioid payout to $465 million Reuters
03:07PM  Oklahoma judge reduces Johnson & Johnson payout in opioid case to $465 million Reuters
12:11PM  Retirement Savers Are Turning to Dividend Stocks for Income. Heres How to Use Them in Your Portfolio. Barrons.com
06:41AM  4 Big Drugmakers to Bet on After a Great Earnings Season Zacks
Nov-14-19 02:54PM  Johnson & Johnson invests in new NYC startup accelerator American City Business Journals
02:02PM  10 Dividend Aristocrats Expected to Deliver Big Gains in 2020 Kiplinger
01:55PM  Top Health Care Stocks for November 2019 Investopedia
09:44AM  FDA Panel Votes Against Lilly's Jardiance for Type I Diabetes Zacks
09:30AM  Why Is Johnson & Johnson (JNJ) Down 2.9% Since Last Earnings Report? Zacks
06:42AM  Rollout of Johnson & Johnson Ebola vaccine begins in Congo Reuters
Nov-13-19 03:43PM  UPDATE 1-J&J blockbuster loses ground to biosimilars despite Quebec court ruling Reuters
02:34PM  Should Investors Add Johnson & Johnson Stock to Their Shopping Lists? InvestorPlace
10:17AM  Abbott Is One Of The Biggest Medical Stocks Should You Buy ABT Stock Now? Investor's Business Daily
09:55AM  UPDATE 1-N.Y. insurance regulator notifies opioid makers, distributors of enforcement action -sources Reuters
09:06AM  Halozyme (HALO) Earnings & Revenues Miss Estimates in Q3 Zacks
01:00AM  J&J's Remicade losing ground in Quebec health plan despite court victory Reuters
Nov-12-19 10:57AM  Jabil Inc. -- Moody's announces completion of a periodic review of ratings of Jabil Inc. Moody's
Nov-11-19 10:32AM  The Zacks Analyst Blog Highlights: Novo Nordisk, Allergan, Sanofi, Novartis and J&J Zacks
09:03AM  AbbVie Eyes Approval for Imbruvica+Rituxan in First-Line CLL Zacks
Nov-08-19 04:13PM  Why It Could Soon Be Time To Take Profits In This Highflying Biotech Stock Investor's Business Daily
11:31AM  Pacira's (PCRX) Q3 Earnings Top Estimates, Revenues Rise Y/Y Zacks
09:26AM  Pharma Stock Roundup: AGN, NVO Q3 Earnings, FDA Nod to SNY & NVS' Products Zacks
06:33AM  Nan Goldin on art, addiction and her battle with the Sacklers over opioids Financial Times
05:00AM  What Happened at Mithril When Peter Thiel Wasnt Around Bloomberg
Nov-07-19 02:33PM  Teva climbs despite earnings miss Yahoo Finance Video
12:58PM  Peter Thiels VC Firm Is Sued by Its Former Top Lawyer Bloomberg
11:53AM  Biotech Stock On The Radar: Alkermes At A Crossroads Benzinga
10:40AM  Teva and Other Opioid Defendant Stocks Jump on Strong Earnings Barrons.com
09:04AM  Special Report: How plaintiff lawyers help corporate America keep its secrets Reuters
08:50AM  Geron (GERN) Q3 Earnings Beat Estimates, Stock Gains 4.1% Zacks
06:44AM  UPDATE 1-Johnson & Johnson files for European approval of Ebola vaccine Reuters
06:18AM  Johnson & Johnson files for European approval of Ebola vaccine Reuters
Nov-06-19 12:37PM  Teva earnings preview: Opioid suits are key MarketWatch
11:19AM  Theravance (TBPH) Q3 Loss In Line, Revenues Lag Estimates Zacks
Nov-05-19 08:30AM  Should iShares Russell Top 200 Value ETF (IWX) Be on Your Investing Radar? Zacks
Nov-04-19 05:20PM  Smead Value Fund Focuses on Cyclicals in 3rd Quarter GuruFocus.com
12:33PM  Smead Value Fund Exits Johnson & Johnson, Trims Paypal GuruFocus.com
12:28PM  Marine algae keys Chinese claim to Alzheimers breakthrough MarketWatch
11:15AM  Medical Products' Earnings Roster for Nov 5: BDX, ZBH & More Zacks
Nov-01-19 02:47PM  AbbVie (ABBV) Beats on Q3 Earnings & Sales, Tweaks EPS View Zacks
11:55AM  Pharma Stock Roundup: MRK, PFE, GSK, BMY Q3 Earnings, Other Updates Zacks
09:00AM  New Tests Find No Asbestos In J&J Baby Powder Is JNJ Stock A Safe Buy? Investor's Business Daily
Oct-31-19 11:27AM  Glaxo (GSK) Beats Q3 Earnings Estimates, Raises '19 EPS View Zacks
11:25AM  Stock Market News For Oct 31, 2019 Zacks
11:15AM  Medtronic Introduces Robotics Challenger to Intuitive System GuruFocus.com
06:30AM  Dicerna ropes in Roche on gene-silencing deal worth up to $1.67B American City Business Journals
Oct-30-19 04:24PM  Dow Jones Today: Another Tepid Reaction to a Fed Rate Cut InvestorPlace
04:16PM  S&P 500 closes at record high after Fed cuts interest rates by a quarter point MarketWatch
04:02PM  U.S. Stocks Rise to Record, Treasuries Gain on Fed: Markets Wrap Bloomberg
03:45PM  4 Top Stock Trades for Thursday: FB, JNJ, EA, AMD InvestorPlace
03:01PM  Jim Cramer: Drug Stocks Are Too Cheap TheStreet.com
02:51PM  Johnson & Johnson, McDonald's share gains contribute to Dow's nearly 75-point climb MarketWatch
01:05PM  Johnson & Johnson's stock surge lifts the Dow into positive territory after baby powder tests show no asbestos MarketWatch
12:44PM  Medical Instruments' Oct 31 Earnings Roster: IDXX, ABMD & More Zacks
11:33AM  US STOCKS-Wall Street flat on mixed earnings; all eyes on Fed Reuters
10:46AM  Best Dividend Stocks for November 2019 Investopedia
10:34AM  Bayer (BAYRY) Q3 Earnings Beat Estimates, Sales Rise Y/Y Zacks
10:22AM  US STOCKS-Wall Street dips as focus shifts to Fed Reuters
09:50AM  Johnson & Johnson Says Independent Labs Found No Asbestos In Recalled Powder Benzinga
08:58AM  US STOCKS-Wall Street set to open slightly higher; Fed decision looms Reuters
08:53AM  The Dow Is Going Nowhere, but GE and Mattel Stock Is Rising Barrons.com
08:32AM  Johnson & Johnson Stock Is Rising After Baby-Powder Tests Revealed No Asbestos Barrons.com
07:36AM  US STOCKS-Futures flat as earnings pour in; Fed decision looms Reuters
06:22AM  Exclusive: J&J's own expert, working for FDA, found asbestos in Baby Powder Reuters
06:15AM  Exclusive: J&J's own expert, working for FDA, found asbestos in Baby Powder Reuters
04:22AM  Stocks - Mattel, Johnson & Johnson Rise Premarket; EA, Yum Brands Falls Investing.com
Oct-29-19 09:26PM  Johnson & Johnson says testing shows no asbestos in baby powder Financial Times
04:51PM  JNJ Stock Pops After New Testing Finds No Asbestos In Baby Powder Investor's Business Daily
04:12PM  REFILE-UPDATE 4-J&J says new tests find no asbestos in same baby powder bottle that sparked recall Reuters
03:56PM  J&J says new tests find no asbestos in same baby power bottle that sparked recall Reuters
03:56PM  J&J says new tests find no asbestos in same baby powder bottle that sparked recall Reuters
03:38PM  Yacktman Focused Fund Trims Procter & Gamble, Microsoft GuruFocus.com
01:12PM  [video]Johnson & Johnson Jumps After Baby Powder Tests Show no Asbestos TheStreet.com
12:48PM  The Kiplinger Dividend 15: Our Favorite Dividend-Paying Stocks Kiplinger
10:30AM  Merck (MRK) Beats on Q3 Earnings & Sales, Raises '19 View Zacks
Oct-28-19 07:03PM  Justice Department issues grand jury subpoenas in J&J opioid probe: filing Reuters
02:00PM  Can Johnson and Johnson Survive this Latest Controversy? InvestorPlace
11:06AM  Dow up 110 points on gains in shares of Microsoft, Goldman Sachs MarketWatch
09:31AM  Imbruvica to Offset Humira Woes in AbbVie (ABBV) Q3 Earnings? Zacks
Oct-25-19 03:46PM  UPDATE 2-Walgreens, Target remove all 22-ounce J&J baby powder from their shelves Reuters
12:55PM  Johnson & Johnson update: More retailers pull baby powder, opioid settlement possible American City Business Journals
11:10AM  What's in the Cards for AbbVie (ABBV) This Earnings Season? Zacks
11:08AM  Target removes all 22-ounce J&J baby powder from its shelves Reuters
10:51AM  Lannett (LCI) to Report Q1 Earnings: What's in the Cards? Zacks
10:31AM  The 3 Best Stocks to Buy and Hold (Forever) Investopedia
10:31AM  Pharma Stock Roundup: LLY, NVS, AZN's Q3 Earnings, Updates From FDA Zacks
07:10AM  Investors Should Short JNJ Stock and Buy Boeing Stock InvestorPlace
12:51AM  Walmart, CVS pull J&J baby powder from shelves Reuters Videos
Oct-24-19 08:25PM  Walmart, CVS Pulling J&J Baby Powder Off Shelves Amid Recall Bloomberg
04:27PM  CORRECTED-US STOCKS-Strong tech results propel S&P 500, Nasdaq Reuters
03:39PM  UPDATE 7-Big U.S. retailers pull 22-ounce J&J baby powder off shelves after recall Reuters
03:25PM  3M, Cisco share losses lead the way, but Dow flat MarketWatch
02:01PM  Johnson & Johnson -- Moody's: J&J's proposed opioid agreement credit negative Moody's
11:18AM  Johnson & Johnson Cut Its Earnings in a Late-Night Filing. Heres Why. Barrons.com
10:06AM  Alkermes' (ALKS) Earnings and Sales Beat Estimates in Q3 Zacks
06:00AM  Several states wary of $48 billion opioid settlement proposal Reuters
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LE PETITE MARSEILLAIS, NEUTROGENA, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides orthopedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular diseases; sterilization and disinfection products to reduce surgical infection; diabetes care products; and vision care products, such as disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and health care professionals for prescription use. It has research and collaboration alliance with Morphic Therapeutic. The company was incorporated in 1887 and is based in New Brunswick, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HEWSON MARILLYN ADirectorJun 11Buy139.683,000419,0403,000Jun 11 05:01 PM
Stoffels PaulusVice Chair, Exec CommitteeFeb 11Option Exercise0.0031,4280242,246Feb 12 09:15 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 11Option Exercise0.009,748078,388Feb 12 09:15 PM
Ullmann Michael HExec VP, General CounselFeb 11Option Exercise0.0013,2730139,434Feb 12 09:15 PM
Wengel Kathryn EEVP, Chief GSC OfficerFeb 11Option Exercise0.006,722044,546Feb 12 09:15 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 11Option Exercise0.0012,609093,947Feb 12 09:15 PM
Wolk Joseph JExec VP, CFOFeb 11Option Exercise0.002,903014,405Feb 12 09:15 PM
Kapusta Ronald AController, CAOFeb 11Option Exercise0.002,839018,231Feb 12 09:15 PM
Duato JoaquinVice Chair, Exec CommitteeFeb 11Option Exercise0.0022,6240122,430Feb 12 09:14 PM
Gorsky AlexChairman, CEOFeb 11Option Exercise0.0073,9470414,703Feb 12 09:14 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesFeb 11Option Exercise0.007,541021,809Feb 12 09:14 PM
Mesquita Jorge S.Exec VP, WW Chair, ConsumerFeb 11Option Exercise0.0016,968036,138Feb 12 09:14 PM
Sneed Michael EEVP, Global Corp Aff & COOFeb 11Option Exercise0.007,275051,687Feb 12 09:14 PM
Stoffels PaulusVice Chair, Exec CommitteeFeb 08Option Exercise0.0012,5710215,138Feb 12 09:15 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 08Option Exercise0.008,529072,205Feb 12 09:15 PM
Ullmann Michael HExec VP, General CounselFeb 08Option Exercise0.005,3090128,294Feb 12 09:15 PM
Wengel Kathryn EEVP, Chief GSC OfficerFeb 08Option Exercise0.005,882040,197Feb 12 09:15 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 08Option Exercise0.005,044083,371Feb 12 09:15 PM
Wolk Joseph JExec VP, CFOFeb 08Option Exercise0.002,540012,239Feb 12 09:15 PM
Kapusta Ronald AController, CAOFeb 08Option Exercise0.002,484016,125Feb 12 09:15 PM
Duato JoaquinVice Chair, Exec CommitteeFeb 08Option Exercise0.009,0490102,604Feb 12 09:14 PM
Gorsky AlexChairman, CEOFeb 08Option Exercise0.0029,5790352,464Feb 12 09:14 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesFeb 08Option Exercise0.006,599016,092Feb 12 09:14 PM
Mesquita Jorge S.Exec VP, WW Chair, ConsumerFeb 08Option Exercise0.006,787022,179Feb 12 09:14 PM
Sneed Michael EEVP, Global Corp Aff & COOFeb 08Option Exercise0.006,365046,239Feb 12 09:14 PM
PRINCE CHARLESDirectorDec 14Buy134.372,000268,73128,520Dec 17 08:37 AM
MULCAHY ANNE MDirectorDec 14Buy133.76748100,0506,537Dec 17 08:37 AM
PEREZ WILLIAM DDirectorDec 14Buy133.911,000133,9109,122Dec 17 08:37 AM
Kapusta Ronald AController, CAODec 13Sale147.313,643536,63813,641Dec 14 04:33 PM
Fasolo PeterExec VP, Chief HR OfficerDec 04Option Exercise96.7341,5634,020,237119,890Dec 06 05:27 PM
Fasolo PeterExec VP, Chief HR OfficerDec 04Sale146.6841,5636,096,55278,327Dec 06 05:27 PM
Fasolo PeterExec VP, Chief HR OfficerDec 03Option Exercise94.12125,13211,777,919203,459Dec 06 05:27 PM
Fasolo PeterExec VP, Chief HR OfficerDec 03Sale146.32125,13218,308,68978,327Dec 06 05:27 PM
Sneed Michael EEVP, Global Corp Aff & COONov 23Option Exercise58.3330,9431,804,90570,817Nov 27 06:56 PM
Sneed Michael EEVP, Global Corp Aff & COONov 23Sale142.4630,9434,407,98539,874Nov 27 06:56 PM